Showing results (361-370 of 475) with videos related to
Sort By:
Pageof 48
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 2010
Hallmark features of immunosenescence are absent in familial longevityEvelyna Derhovanessian, Andrea B Maier, Robert Beck, et al.Immunity & Ageing : I & A|August 30, 2012
Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus StudySijia Chen, Anton J M de Craen, Yotam Raz, et al.Age (Dordrecht, Netherlands)|June 5, 2012
Lower proportion of naïve peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly peopleEvelyna Derhovanessian, Andrea B Maier, Karin Hähnel, et al.Journal of Neuroimmunology|December 14, 2011
Immune profiling of Alzheimer patientsMariavaleria Pellicanò, Anis Larbi, David Goldeck, et al.Ageing Research Reviews|November 2, 2020
Aging in COVID-19: Vulnerability, immunity and interventionYiyin Chen, Sabra L Klein, Brian T Garibaldi, et al.International Journal of Pharmaceutics|July 3, 2021
Novel immunomodulatory properties of low dose cytarabine entrapped in a mannosylated cationic liposomeAlexandrine L Martel, Nya L Fraleigh, Emilie Picard, et al.International Journal of Epidemiology|March 19, 2013
Cohort profile: The Berlin Aging Study II (BASE-II)Lars Bertram, Anke Böckenhoff, Ilja Demuth, et al.Cancer Immunology, Immunotherapy : CII|January 25, 2002
HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clonesSonia A Perez, Panagiota A Sotiropoulou, Nectaria N Sotiriadou, et al.Vaccines|April 23, 2022
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to ChangeTamas Fulop, Anis Larbi, Graham Pawelec, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2016
Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma PatientsKilian Wistuba-Hamprecht, Alexander Martens, Benjamin Weide, et al.Pageof 48